Cargando…
Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization
The tumor vasculature was different from the normal vasculature in both function and morphology, which caused hypoxia in the tumor microenvironment (TME). Previous anti-angiogenesis therapy had led to a modest improvement in cancer immunotherapy. However, antiangiogenic therapy only benefitted a few...
Autores principales: | Li, Yang, Fu, Lei, Wu, Baokang, Guo, Xingqi, Shi, Yu, Lv, Chao, Yu, Yang, Zhang, Yizhou, Liang, Zhiyun, Zhong, Chongli, Han, Shukun, Xu, Feng, Tian, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474740/ https://www.ncbi.nlm.nih.gov/pubmed/37660019 http://dx.doi.org/10.1186/s12935-023-03044-z |
Ejemplares similares
-
Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma
por: Wu, Baokang, et al.
Publicado: (2023) -
Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth
por: PJ, Noy, et al.
Publicado: (2015) -
CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis
por: Li, Yang, et al.
Publicado: (2022) -
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022) -
Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer
por: Lv, Chao, et al.
Publicado: (2022)